Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cencora, Inc. stock logo
COR
Cencora
$299.48
+0.0%
$290.31
$218.65
$309.35
$58.03B0.581.50 million shs1.28 million shs
CVS Health Corporation stock logo
CVS
CVS Health
$68.91
+0.6%
$64.86
$43.56
$72.51
$86.64B0.5610.84 million shs6.05 million shs
Philip Morris International Inc. stock logo
PM
Philip Morris International
$182.20
+0.6%
$175.96
$100.80
$186.69
$281.78B0.525.61 million shs5.25 million shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cencora, Inc. stock logo
COR
Cencora
0.00%+2.06%+2.82%+7.74%+33.03%
CVS Health Corporation stock logo
CVS
CVS Health
0.00%+2.72%+7.05%+1.06%+15.99%
Philip Morris International Inc. stock logo
PM
Philip Morris International
0.00%-0.80%+0.20%+14.01%+78.73%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cencora, Inc. stock logo
COR
Cencora
4.6407 of 5 stars
2.43.03.33.13.63.31.3
CVS Health Corporation stock logo
CVS
CVS Health
4.8971 of 5 stars
2.53.03.33.92.23.33.1
Philip Morris International Inc. stock logo
PM
Philip Morris International
3.9768 of 5 stars
2.53.03.30.03.61.71.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cencora, Inc. stock logo
COR
Cencora
2.82
Moderate Buy$306.332.29% Upside
CVS Health Corporation stock logo
CVS
CVS Health
2.95
Moderate Buy$75.389.38% Upside
Philip Morris International Inc. stock logo
PM
Philip Morris International
2.91
Moderate Buy$176.80-2.96% Downside

Current Analyst Ratings Breakdown

Latest PM, COR, and CVS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/30/2025
Cencora, Inc. stock logo
COR
Cencora
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$275.00 ➝ $300.00
6/30/2025
CVS Health Corporation stock logo
CVS
CVS Health
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$74.00 ➝ $80.00
6/13/2025
Philip Morris International Inc. stock logo
PM
Philip Morris International
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$205.00 ➝ $220.00
6/4/2025
Philip Morris International Inc. stock logo
PM
Philip Morris International
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$182.00 ➝ $200.00
6/3/2025
Cencora, Inc. stock logo
COR
Cencora
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$274.00 ➝ $337.00
6/2/2025
CVS Health Corporation stock logo
CVS
CVS Health
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOverweight ➝ Overweight$82.00 ➝ $79.00
5/22/2025
Philip Morris International Inc. stock logo
PM
Philip Morris International
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy
5/22/2025
Philip Morris International Inc. stock logo
PM
Philip Morris International
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeModerate Buy$195.00
5/12/2025
CVS Health Corporation stock logo
CVS
CVS Health
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$82.00 ➝ $84.00
5/8/2025
Cencora, Inc. stock logo
COR
Cencora
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$330.00 ➝ $355.00
5/8/2025
Cencora, Inc. stock logo
COR
Cencora
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$314.00 ➝ $350.00
(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cencora, Inc. stock logo
COR
Cencora
$293.96B0.20$19.89 per share15.06$4.04 per share74.13
CVS Health Corporation stock logo
CVS
CVS Health
$372.81B0.23$9.14 per share7.54$60.18 per share1.15
Philip Morris International Inc. stock logo
PM
Philip Morris International
$89.44B3.17$7.81 per share23.34($6.35) per share-28.69
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cencora, Inc. stock logo
COR
Cencora
$1.51B$8.6234.7417.741.480.55%344.71%4.26%7/30/2025 (Estimated)
CVS Health Corporation stock logo
CVS
CVS Health
$4.61B$4.1916.4510.180.981.39%10.59%3.17%8/6/2025 (Estimated)
Philip Morris International Inc. stock logo
PM
Philip Morris International
$7.06B$4.8537.5723.062.628.43%-122.40%16.25%7/22/2025 (Estimated)

Latest PM, COR, and CVS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/22/2025Q2 2025
Philip Morris International Inc. stock logo
PM
Philip Morris International
$1.84N/AN/AN/A$10.33 billionN/A
5/7/2025Q2 2025
Cencora, Inc. stock logo
COR
Cencora
$4.07$4.42+$0.35$3.68$75.41 billion$75.50 billion
5/1/2025Q1 2025
CVS Health Corporation stock logo
CVS
CVS Health
$1.62$2.25+$0.63$1.41$93.07 billion$94.59 billion
4/23/2025Q1 2025
Philip Morris International Inc. stock logo
PM
Philip Morris International
$1.61$1.69+$0.08$1.72$9.10 billion$9.30 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cencora, Inc. stock logo
COR
Cencora
$2.200.73%N/A25.52%15 Years
CVS Health Corporation stock logo
CVS
CVS Health
$2.663.86%N/A63.48%4 Years
Philip Morris International Inc. stock logo
PM
Philip Morris International
$5.402.96%N/A111.34%17 Years

Latest PM, COR, and CVS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/13/2025
Philip Morris International Inc. stock logo
PM
Philip Morris International
quarterly$1.352.94%6/27/20256/27/20257/15/2025
5/8/2025
Cencora, Inc. stock logo
COR
Cencora
quarterly$0.550.8%5/16/20255/16/20256/2/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cencora, Inc. stock logo
COR
Cencora
6.01
0.87
0.52
CVS Health Corporation stock logo
CVS
CVS Health
0.77
0.82
0.63
Philip Morris International Inc. stock logo
PM
Philip Morris International
N/A
0.79
0.43

Institutional Ownership

CompanyInstitutional Ownership
Cencora, Inc. stock logo
COR
Cencora
97.52%
CVS Health Corporation stock logo
CVS
CVS Health
80.66%
Philip Morris International Inc. stock logo
PM
Philip Morris International
78.63%

Insider Ownership

CompanyInsider Ownership
Cencora, Inc. stock logo
COR
Cencora
10.80%
CVS Health Corporation stock logo
CVS
CVS Health
1.22%
Philip Morris International Inc. stock logo
PM
Philip Morris International
0.13%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cencora, Inc. stock logo
COR
Cencora
46,000193.82 million172.89 millionOptionable
CVS Health Corporation stock logo
CVS
CVS Health
300,0001.27 billion1.25 billionOptionable
Philip Morris International Inc. stock logo
PM
Philip Morris International
83,1001.56 billion1.55 billionOptionable

Recent News About These Companies

Philip Morris: Balanced Risk With Smoke-Free Transition
PM - Philip Morris International Inc Chart - Morningstar

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Cencora stock logo

Cencora NYSE:COR

$299.48 +0.06 (+0.02%)
As of 03:58 PM Eastern

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

CVS Health stock logo

CVS Health NYSE:CVS

$68.91 +0.42 (+0.61%)
As of 03:58 PM Eastern

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

Philip Morris International stock logo

Philip Morris International NYSE:PM

$182.20 +1.17 (+0.65%)
As of 03:58 PM Eastern

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products primarily under the IQOS and ZYN brands; and consumer accessories, such as lighters and matches. It also offers wellness and healthcare products. Philip Morris International Inc. was incorporated in 1987 and is headquartered in Stamford, Connecticut.